Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Vision and vision-related outcome measures in multiple sclerosis.
Longitudinal assessment of clinically isolated syndrome with diffusion tensor imaging and volumetric MRI.
Presentation of multiple sclerosis with comorbid Huntington's disease.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Multiple sclerosis and pregnancy prescriptions.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Outcome of children with acute disseminated encephalomyelitis in a tertiary care center in India.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania.
Onset of neuromyelitis optica in the elderly.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study.
Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study.
Early respiratory evaluation should be carried out systematically in patients with multiple sclerosis.
Predicting medication adherence in multiple sclerosis using telephone-based home monitoring.
Erratum.
Variants of Interleukin-7/Interleukin-7 Receptor Alpha are Associated with Both Neuromyelitis Optica and Multiple Sclerosis Among Chinese Han Population in Southeastern China.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group.
Co-occurring Depression and Pain in Multiple Sclerosis.
Disease course heterogeneity and OCT in multiple sclerosis.
The role of assessment in enhancing the vocational success of people with multiple sclerosis.
Pages
« first
‹ previous
…
613
614
615
616
617
618
619
620
621
…
next ›
last »